Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “To Determine Bioequivalence Under Fasting Conditions”

51 trials

Showing 20 of 51 results

Early research (Phase 1)Study completedNCT02750709
What this trial is testing

Bioequivalence Study of Two Nitisinone Formulations Compared to Orfadin

Who this might be right for
Hereditary Tyrosinemia, Type I
Cycle Pharmaceuticals Ltd. 24
Early research (Phase 1)Study completedNCT00653419
What this trial is testing

Bioavailability Study of (Buspar) Buspirone HCl Tablets Under Fasting Conditions

Who this might be right for
To Determine Bioequivalence Under Fasting Conditions
Par Pharmaceutical, Inc. 48
Early research (Phase 1)WithdrawnNCT02980757
What this trial is testing

Bioequivalence Study of Gliclazide 120 mg Modified Release Tablets

Who this might be right for
Comparative Bioavailability
Disphar International B.V.
Early research (Phase 1)Study completedNCT00653055
What this trial is testing

Bioequivalence Study of Cabergoline Tablets and Dostinex Under Fasting Conditions

Who this might be right for
To Determine Bioequivalence Under Fasting Conditions
Par Pharmaceutical, Inc. 40
Early research (Phase 1)Study completedNCT00653380
What this trial is testing

Bioavailability Study of Doxycycline Monohydrate Capsules and Monodox Under Fasting Conditions

Who this might be right for
To Determine Bioequivalence Under Fasting Conditions
Par Pharmaceutical, Inc. 24
Post-approval studies (Phase 4)Study completedNCT02446496
What this trial is testing

A Bioequivalence Study of Cefadroxil Film Coated Tablets After A Single Oral Dose Administration to Healthy Subjects

Who this might be right for
Infections, Urinary Tract
GlaxoSmithKline 24
Early research (Phase 1)Study completedNCT00652639
What this trial is testing

Bioavailability Study of Clonazepam Tablets Under Fasting Conditions

Who this might be right for
To Determine Bioequivalence Under Fasting Conditions
Par Pharmaceutical, Inc. 32
Early research (Phase 1)Study completedNCT02201316
What this trial is testing

A Pilot Study to Determine the Relative Bioavailability of Mosapride 5mg From Two Candidate Formulations of GR107719B Relative to One 5mg Tablet of Reference Mosapride Citrate (GASMOTIN™) in Healthy Adult Human Subjects Under Fasting Conditions

Who this might be right for
Gastritis
GlaxoSmithKline 18
Early research (Phase 1)Study completedNCT00653393
What this trial is testing

Bioavailability Study of Tranylcypromine 10mg Tablets Under Fasting Conditions

Who this might be right for
To Determine the Bioavailability of Tranylcypromine
Par Pharmaceutical, Inc. 39
Early research (Phase 1)Study completedNCT02502812
What this trial is testing

Bioequivalence Study of Clopidogrel 75 mg in Two Tablet Formulations Relative to Reference Tablet in Healthy Subjects

Who this might be right for
Cardiovascular Disease
GlaxoSmithKline 18
Early research (Phase 1)Study completedNCT02516098
What this trial is testing

Determine the Bioequivalence of Two Formulations of Hyoscine Butylbromide.

Who this might be right for
Healthy
Boehringer Ingelheim 56
Early research (Phase 1)Study completedNCT00653315
What this trial is testing

Bioavailability Study of Tramadol/APAP Tablets Under Fasting Conditions

Who this might be right for
To Determine Bioequivalence Under Fasting Conditions
Par Pharmaceutical, Inc. 28
Early research (Phase 1)Study completedNCT00659074
What this trial is testing

Bioavailability Study of Ondansetron 24 mg Orally Disintegrating Tablets Under Fasting Conditions

Who this might be right for
Healthy
Par Pharmaceutical, Inc. 24
Early research (Phase 1)Study completedNCT00653549
What this trial is testing

Bioavailability Study of Torsemide Tablets Under Fasting Conditions

Who this might be right for
To Determine Bioequivalence Under Fasting Conditions
Par Pharmaceutical, Inc. 26
Post-approval studies (Phase 4)Study completedNCT02446483
What this trial is testing

A Bioequivalence Study of Idiazole 20mg DR Tabs and PARIET® 20 mg DR Tabs After a Single Oral Dose Administration Under Fasting Conditions in Healthy Adults

Who this might be right for
Gastrointestinal Diseases
GlaxoSmithKline 60
Early research (Phase 1)Study completedNCT02767310
What this trial is testing

Study to Determine the Bioequivalence of Two Products Containing Rosuvastatin (20 mg/Tablet)

Who this might be right for
Healthy
Verisfield UK Ltd. Greek Branch 49
Early research (Phase 1)Study completedNCT01380483
What this trial is testing

Bioequivalence Study of Doxycycline Monohydrate Tablets Under Fasting Conditions

Who this might be right for
To Determine Bioequivalence Under Fasting Conditions
Par Pharmaceutical, Inc. 40
Early research (Phase 1)Study completedNCT01380457
What this trial is testing

Bioavailability Study of Dronabinol Capsules 10 mg Under Fasting Conditions

Who this might be right for
To Determine Bioequivalence Under Fasting Conditions
Par Pharmaceutical, Inc. 69
Early research (Phase 1)Study completedNCT02006589
What this trial is testing

Bioavailability Study of Candesartan Cilexetil 8mg Tablet Under Fasting Conditions

Who this might be right for
Hypertension
GlaxoSmithKline 16
Early research (Phase 1)Study completedNCT04476966
What this trial is testing

Bioequivalence Study of Mirabegron From Bladogra 25 mg Extended Release Tablets (Multi-Apex for Pharmaceutical Industries, Egypt) Versus Myrbetriq 25 mg Extended Release Tablets (Marketed by Astellas Pharma US, Inc, Product of Japan)

Who this might be right for
Healthy
Genuine Research Center, Egypt 29
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation